January 2016 | Oncology Business News®

January 26, 2016

Having an evidence package at launch that satisfies payers’ value criteria will increase the likelihood that payers will reimburse the drug at a desirable price and enable patient access to innovative treatments.

January 20, 2016

Competition, consolidation and attrition have reduced the number of oncology players in the Salt Lake City region, but business has never been better at Utah Cancer Specialists.

January 18, 2016

More models of care are beginning to show signs of recognition that palliative care has a larger role to play in the oncology setting.

January 18, 2016

Looking back on 2015 in the field of oncology practice, a lot of the groundwork was laid for what the Association of Community Cancer Centers predicted in a fall report: “increased reliance on team-based care and care provided by nonphysicians.”

January 14, 2016

One best practice identified for transforming quality, safety and efficiency in healthcare is the use of clinical decision support tools.

January 05, 2016

Unsuccessful efforts have been made to improve the quality of information provided to consumers about advertised drugs, and against that backdrop, the American Medical Association has called for an outright ban on direct-to-consumer drug advertising.

January 04, 2016

As more studies link aggressive end-of-life oncology care to problems such as suboptimal cost and quality outcomes, experts are increasingly proposing earlier, more comprehensive palliative care interventions.

January 02, 2016

Tremendous consolidation of remaining independent oncology practices is very likely under scenarios.

January 01, 2016

The high cost of deductibles and copays under Affordable Care Act health exchange policies is a barrier in oncological care that renders the discussion of patient involvement in therapy choices somewhat moot.